Pharma
Solifen 5mg (Solifenacin Succinate Tablets)
Antimuscarinic agent; 5mg Solifenacin Succinate tablets for overactive bladder symptoms.
Solifen 5mg (Solifenacin Succinate Tablets)
Solifen contains 5mg of Solifenacin Succinate, a competitive muscarinic receptor antagonist. It is primarily indicated for the symptomatic treatment of urge incontinence and/or increased urinary frequency and urgency as may occur in patients with overactive bladder (OAB) syndrome. By relaxing the muscles in the bladder, it helps improve the ability to control urination. Common side effects include dry mouth, constipation, and blurred vision. It should be used with caution in patients with glaucoma or severe kidney/liver issues.
You May Also Like
Combination DPP-4 inhibitor and Biguanide; 50 mg/500 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/1000 mg Sitagliptin/Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50mg/500mg Vildagliptin/Metformin tablets for Type 2 Diabetes control.
Triple antidiabetic combo; Dapagliflozin 10 mg, Sitagliptin 100 mg, and Metformin ER 1000 mg (28 tablets) for Type 2 Diabetes.